Manchester facility boosts biotechnology
A new £25 million facility dedicated to finding new treatments for diseases such as HIV and cancer was launched at The University of Manchester today.
The Core Technology Facility (CTF) labs are already looking at ways to grow replacement tissue, such as veins and arteries, and even whole organs that could one day be transplanted into patients suffering from conditions such as heart disease and diabetes.
The CTF will provide specialist accommodation for biotech companies as well as academic staff from the university's Faculties of Life Sciences and Medical and Human Sciences.
The facility will encourage commercial exploitation of these university research activities by providing integrated space in which young businesses can work alongside University research groups. The CTF is being launched by The University of Manchester Incubator Company Limited (UMIC), which manages a portfolio of business incubators on behalf of the university.
Science and Innovation Minister Lord Sainsbury officially opened the new development today.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
UK Automotive Feeling The Pinch Of Skills Shortage
Not so much attracting skills to the UK but generating skills within the UK is what is needed! That statement suggest they are in effect wanting to...